The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/15710
StudyName: Eligibility Non-Small Cell Lung Cancer NCT02367794
Date of export from the portal: 02.07.2020
Date of Upload / last change: 09.06.2016
License: Creative Commons BY 4.0

----

Description: 
A Phase III Study of MPDL3280A (Anti-PD-L1) in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-paclitaxel Compared With Carboplatin + Nab-paclitaxel in Patients With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower 131]; ODM derived from: https://clinicaltrials.gov/show/NCT02367794
